3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
44
Liver Neoplasms
18
Colorectal Neoplasms
15
Neoplasm Metastasis
11
Cholangiocarcinoma
11
Pancreatic Neoplasms
9
Colonic Neoplasms
9
Barrett Esophagus
7
Rectal Neoplasms
6
Recurrence
5
Esophageal Neoplasms
4
Biliary Tract Neoplasms
3
Bile Duct Neoplasms
3
Hepatitis B
2
Gallbladder Neoplasms
2
Stomach Neoplasms
1
Solid Tumor Including Thyroid, Bone, Liver, Pancreas
1
Pancreatic cancer, adult
1
Pancreatic Neuroendocrine Tumors, WHO Grade I-II
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasms, Glandular and Epithelial
1
Neoplasms
1
Neoplasm Micrometastasis
1
Multi-organ Metastatic Colorectal Cancer
1
Liver Metastasis Colon Cancer
1
Klatskin Tumor
1
Jaundice, Obstructive
1
Hypertension, Portal
1
Hepatitis B, Chronic
1
Interventions
Gemcitabine
6
Cisplatin
6
Capecitabine
6
Liver Transplantation
4
Fluorouracil
4
Specimen Handling
3
Radiosurgery
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
toripalimab
2
dehydroftorafur
2
Self Expandable Metallic Stents
2
Platinum
2
Leucovorin
2
Biopsy
2
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide
2
1,2-diaminocyclohexaneplatinum II citrate
2
trisacryl gelatin microspheres
1
tremelimumab
1
trametinib
1
tislelizumab
1
temoporfin
1
sacituzumab govitecan
1
ricolinostat
1
pembrolizumab
1
lenvatinib
1
gemcitabine-oxaliplatin regimen
1
fludarabine
1
durvalumab
1
binimetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Klatskin Tumor
×
Radiofrequency Ablation
×
Gastrointestinal
×
Clear all
NCT05551299
2025-03-27
CARP
University of Leipzig
Phase 4
Recruiting
258 enrolled